Corsalex Postdoctoral Fellowship Program

The Corsalex Postdoctoral Fellowship Program is designed to support promising early-career scientists who wish to enter to continue research in the field of C9orf72 ALS/FTD. Fellows receive up to $210,000 over 3 years to support research of high scientific merit and relevance to C9 (full details here). 

Important dates:

February 1, 2025: Applications open

July 1, 2025: Deadline for submissions

September, 2025 (or later): Fellowship starts

Learn more about Corsalex here.


Who Should Apply

  • Junior postdoctoral researcher with a designated advisor in an ALS or FTD-focused lab

  • For recent graduates, must hold a PhD certificate on the day of submission with an offer letter from the hosting PI

  • Must be no more than 1 year into postdoctoral fellowship

  • Open to all nationalities and positions anywhere in the world


Reason for the Program

Our mission at Corsalex is to develop therapies to treat C9orf72 ALS/FTD. While Corsalex is a drug development company, we are interested in advancing the field of C9 in any way that we can. We want to spur innovation in the field by investing in promising research that could ultimately help bring drugs to patients.


What We Are Looking For

The Corsalex Fellowship will fund projects that are primarily focused on research in C9orf72. We are interested in projects that focus on (among others topics):

  • The underlying biology of C9orf72 ALS/FTD

  • Novel drug targets or biomarkers

  • Gene therapies

  • Drug delivery into the CNS

  • Disease models


What the Fellowship Offers

  • Research salary and fringe benefits

  • Travel stipend to relevant conferences and in-person meetings with the Corsalex team

  • Mentorship from the Corsalex team with semi-annual meetings

  • Hands-on exposure to biotech drug development with a focus on translating academic research

  • Access to our network of collaborators and industry partners